Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akihiro Kitadate

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Oncotarget|February 8, 2019
Improved survival outcomes and relative youthfulness of multiple myeloma patients with t(4;14) receiving novel agents are associated with poorer performance of the revised international staging system in a real aging societyYoshiaki Abe, Kazutaka Sunami, Takeshi Yamashita, et al.
Clinical Nuclear Medicine|March 20, 2019
Diagnostic and Prognostic Value of Using 18F-FDG PET/CT for the Evaluation of Bone Marrow Involvement in Peripheral T-Cell LymphomaYoshiaki Abe, Akihiro Kitadate, Yoshiaki Usui, et al.
British Journal of Haematology|April 22, 2025
Multiple myeloma with 1q gain/amplification exhibits reduced CD38 expression via interleukin-6 receptor overexpressionWataru Kuroki, Akihiro Kitadate, Yuto Takahashi, et al.
Blood|January 4, 2014
MicroRNA-150 inhibits tumor invasion and metastasis by targeting the chemokine receptor CCR6, in advanced cutaneous T-cell lymphomaMitsugu Ito, Kazuaki Teshima, Sho Ikeda, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 8, 2017
Successful management of splenomegaly with ruxolitinib prior to allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia transformed from post-polycythemia vera myelofibrosisMasumi Fujishima, Naohito Fujishima, Akihiro Kitadate, et al.
Cancer Chemotherapy and Pharmacology|August 13, 2022
Safe administration and pharmacokinetic monitoring of crushed venetoclax tablets with posaconazole and clarithromycin via percutaneous endoscopic gastrostomy tube in a patient with acute myeloid leukemiaHonami Sato, Takahiro Kobayashi, Nanako Fujita, et al.
Cureus|January 15, 2024
Ponatinib Improved the Prognosis of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Japanese Single-Center Cohort StudyNagi Tozawa, Takaya Yamashita, Miho Nara, et al.
Oncotarget|December 10, 2016
Histone deacetylase inhibitors inhibit metastasis by restoring a tumor suppressive microRNA-150 in advanced cutaneous T-cell lymphomaFumito Abe, Akihiro Kitadate, Sho Ikeda, et al.
Cancer Science|November 14, 2025
NF-κB Is a Potential Therapeutic Target for Histone Deacetylase Inhibitor-Resistant Cutaneous T-Cell LymphomaYuto Takahashi, Akihiro Kitadate, Sayaka Iwama, et al.
Cancer Medicine|June 20, 2020
Baseline total lesion glycolysis combined with interim positron emission tomography-computed tomography is a robust predictor of outcome in patients with peripheral T-cell lymphomaAkihiro Kitadate, Kentaro Narita, Kouta Fukumoto, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Oncotarget|February 8, 2019
Improved survival outcomes and relative youthfulness of multiple myeloma patients with t(4;14) receiving novel agents are associated with poorer performance of the revised international staging system in a real aging societyYoshiaki Abe, Kazutaka Sunami, Takeshi Yamashita, et al.
Clinical Nuclear Medicine|March 20, 2019
Diagnostic and Prognostic Value of Using 18F-FDG PET/CT for the Evaluation of Bone Marrow Involvement in Peripheral T-Cell LymphomaYoshiaki Abe, Akihiro Kitadate, Yoshiaki Usui, et al.
British Journal of Haematology|April 22, 2025
Multiple myeloma with 1q gain/amplification exhibits reduced CD38 expression via interleukin-6 receptor overexpressionWataru Kuroki, Akihiro Kitadate, Yuto Takahashi, et al.
Blood|January 4, 2014
MicroRNA-150 inhibits tumor invasion and metastasis by targeting the chemokine receptor CCR6, in advanced cutaneous T-cell lymphomaMitsugu Ito, Kazuaki Teshima, Sho Ikeda, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 8, 2017
Successful management of splenomegaly with ruxolitinib prior to allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia transformed from post-polycythemia vera myelofibrosisMasumi Fujishima, Naohito Fujishima, Akihiro Kitadate, et al.
Cancer Chemotherapy and Pharmacology|August 13, 2022
Safe administration and pharmacokinetic monitoring of crushed venetoclax tablets with posaconazole and clarithromycin via percutaneous endoscopic gastrostomy tube in a patient with acute myeloid leukemiaHonami Sato, Takahiro Kobayashi, Nanako Fujita, et al.
Cureus|January 15, 2024
Ponatinib Improved the Prognosis of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Japanese Single-Center Cohort StudyNagi Tozawa, Takaya Yamashita, Miho Nara, et al.
Oncotarget|December 10, 2016
Histone deacetylase inhibitors inhibit metastasis by restoring a tumor suppressive microRNA-150 in advanced cutaneous T-cell lymphomaFumito Abe, Akihiro Kitadate, Sho Ikeda, et al.
Cancer Science|November 14, 2025
NF-κB Is a Potential Therapeutic Target for Histone Deacetylase Inhibitor-Resistant Cutaneous T-Cell LymphomaYuto Takahashi, Akihiro Kitadate, Sayaka Iwama, et al.
Cancer Medicine|June 20, 2020
Baseline total lesion glycolysis combined with interim positron emission tomography-computed tomography is a robust predictor of outcome in patients with peripheral T-cell lymphomaAkihiro Kitadate, Kentaro Narita, Kouta Fukumoto, et al.
Pageof 5